Analysis and Commentary STEVEN GROSSMAN 2/16/18 Analysis and Commentary STEVEN GROSSMAN 2/16/18 And Now for Something a Little Different! Read More Analysis and Commentary STEVEN GROSSMAN 2/9/18 Analysis and Commentary STEVEN GROSSMAN 2/9/18 The President's Budget Request: Separating the Wheat from the Chaff Read More Analysis and Commentary STEVEN GROSSMAN 2/2/18 Analysis and Commentary STEVEN GROSSMAN 2/2/18 The Morning After Effect (on the President's Budget Request) Read More Analysis and Commentary STEVEN GROSSMAN 1/27/18 Analysis and Commentary STEVEN GROSSMAN 1/27/18 Our Crystal Ball Is a Little Cracked, But ... Read More Analysis and Commentary STEVEN GROSSMAN 1/13/18 Analysis and Commentary STEVEN GROSSMAN 1/13/18 Keeping Up with Progress Costs Money! Read More Analysis and Commentary STEVEN GROSSMAN 1/5/18 Analysis and Commentary STEVEN GROSSMAN 1/5/18 Ensuring an Effective and Motivated Workforce Read More Analysis and Commentary STEVEN GROSSMAN 12/22/17 Analysis and Commentary STEVEN GROSSMAN 12/22/17 From This Week's CR into FY 19: More Alliance Priorities Read More Analysis and Commentary STEVEN GROSSMAN 12/15/17 Analysis and Commentary STEVEN GROSSMAN 12/15/17 Right Down to the Wire: Beware and Be Warned! Read More Analysis and Commentary STEVEN GROSSMAN 12/8/17 Analysis and Commentary STEVEN GROSSMAN 12/8/17 "All of Our Voices" Are Going to Be Essential Read More Analysis and Commentary STEVEN GROSSMAN 12/1/17 Analysis and Commentary STEVEN GROSSMAN 12/1/17 No One’s Interests Would Be Served by a Shutdown Read More Analysis and Commentary STEVEN GROSSMAN 11/17/17 Analysis and Commentary STEVEN GROSSMAN 11/17/17 Much to Be Thankful For Read More Analysis and Commentary STEVEN GROSSMAN 11/10/17 Analysis and Commentary STEVEN GROSSMAN 11/10/17 Whatever Makes FDA Stronger (in Resources) ... Read More Analysis and Commentary STEVEN GROSSMAN 11/4/17 Analysis and Commentary STEVEN GROSSMAN 11/4/17 FDA Is Its People ... and They Need Our Support Read More Analysis and Commentary STEVEN GROSSMAN 10/27/17 Analysis and Commentary STEVEN GROSSMAN 10/27/17 Building a Truely 21st Century Regulatory Agency Read More Analysis and Commentary STEVEN GROSSMAN 10/20/17 Analysis and Commentary STEVEN GROSSMAN 10/20/17 Not Your Father's FDA Read More Analysis and Commentary STEVEN GROSSMAN 10/13/17 Analysis and Commentary STEVEN GROSSMAN 10/13/17 The FDA Deserves Special Consideration at Budget-Time Read More Analysis and Commentary STEVEN GROSSMAN 10/6/17 Analysis and Commentary STEVEN GROSSMAN 10/6/17 FDA Stakeholders Need to Start to "Up Our Game" Read More Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More Analysis and Commentary STEVEN GROSSMAN 9/8/17 Analysis and Commentary STEVEN GROSSMAN 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More Analysis and Commentary STEVEN GROSSMAN 8/11/17 Analysis and Commentary STEVEN GROSSMAN 8/11/17 It's Going to Get Tougher From Here Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 2/16/18 Analysis and Commentary STEVEN GROSSMAN 2/16/18 And Now for Something a Little Different! Read More
Analysis and Commentary STEVEN GROSSMAN 2/9/18 Analysis and Commentary STEVEN GROSSMAN 2/9/18 The President's Budget Request: Separating the Wheat from the Chaff Read More
Analysis and Commentary STEVEN GROSSMAN 2/2/18 Analysis and Commentary STEVEN GROSSMAN 2/2/18 The Morning After Effect (on the President's Budget Request) Read More
Analysis and Commentary STEVEN GROSSMAN 1/27/18 Analysis and Commentary STEVEN GROSSMAN 1/27/18 Our Crystal Ball Is a Little Cracked, But ... Read More
Analysis and Commentary STEVEN GROSSMAN 1/13/18 Analysis and Commentary STEVEN GROSSMAN 1/13/18 Keeping Up with Progress Costs Money! Read More
Analysis and Commentary STEVEN GROSSMAN 1/5/18 Analysis and Commentary STEVEN GROSSMAN 1/5/18 Ensuring an Effective and Motivated Workforce Read More
Analysis and Commentary STEVEN GROSSMAN 12/22/17 Analysis and Commentary STEVEN GROSSMAN 12/22/17 From This Week's CR into FY 19: More Alliance Priorities Read More
Analysis and Commentary STEVEN GROSSMAN 12/15/17 Analysis and Commentary STEVEN GROSSMAN 12/15/17 Right Down to the Wire: Beware and Be Warned! Read More
Analysis and Commentary STEVEN GROSSMAN 12/8/17 Analysis and Commentary STEVEN GROSSMAN 12/8/17 "All of Our Voices" Are Going to Be Essential Read More
Analysis and Commentary STEVEN GROSSMAN 12/1/17 Analysis and Commentary STEVEN GROSSMAN 12/1/17 No One’s Interests Would Be Served by a Shutdown Read More
Analysis and Commentary STEVEN GROSSMAN 11/17/17 Analysis and Commentary STEVEN GROSSMAN 11/17/17 Much to Be Thankful For Read More
Analysis and Commentary STEVEN GROSSMAN 11/10/17 Analysis and Commentary STEVEN GROSSMAN 11/10/17 Whatever Makes FDA Stronger (in Resources) ... Read More
Analysis and Commentary STEVEN GROSSMAN 11/4/17 Analysis and Commentary STEVEN GROSSMAN 11/4/17 FDA Is Its People ... and They Need Our Support Read More
Analysis and Commentary STEVEN GROSSMAN 10/27/17 Analysis and Commentary STEVEN GROSSMAN 10/27/17 Building a Truely 21st Century Regulatory Agency Read More
Analysis and Commentary STEVEN GROSSMAN 10/20/17 Analysis and Commentary STEVEN GROSSMAN 10/20/17 Not Your Father's FDA Read More
Analysis and Commentary STEVEN GROSSMAN 10/13/17 Analysis and Commentary STEVEN GROSSMAN 10/13/17 The FDA Deserves Special Consideration at Budget-Time Read More
Analysis and Commentary STEVEN GROSSMAN 10/6/17 Analysis and Commentary STEVEN GROSSMAN 10/6/17 FDA Stakeholders Need to Start to "Up Our Game" Read More
Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More
Analysis and Commentary STEVEN GROSSMAN 9/8/17 Analysis and Commentary STEVEN GROSSMAN 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More
Analysis and Commentary STEVEN GROSSMAN 8/11/17 Analysis and Commentary STEVEN GROSSMAN 8/11/17 It's Going to Get Tougher From Here Read More
